3wj4: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
<StructureSection load='3wj4' size='340' side='right'caption='[[3wj4]], [[Resolution|resolution]] 1.95Å' scene=''> | <StructureSection load='3wj4' size='340' side='right'caption='[[3wj4]], [[Resolution|resolution]] 1.95Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3wj4]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | <table><tr><td colspan='2'>[[3wj4]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3WJ4 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3WJ4 FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.95Å</td></tr> | ||
<tr id=' | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=TBY:TRIBUTYLSTANNANYL'>TBY</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3wj4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3wj4 OCA], [https://pdbe.org/3wj4 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3wj4 RCSB], [https://www.ebi.ac.uk/pdbsum/3wj4 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3wj4 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3wj4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3wj4 OCA], [https://pdbe.org/3wj4 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3wj4 RCSB], [https://www.ebi.ac.uk/pdbsum/3wj4 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3wj4 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
[https://www.uniprot.org/uniprot/PPARG_HUMAN PPARG_HUMAN] Note=Defects in PPARG can lead to type 2 insulin-resistant diabetes and hyptertension. PPARG mutations may be associated with colon cancer. Defects in PPARG may be associated with susceptibility to obesity (OBESITY) [MIM:[https://omim.org/entry/601665 601665]. It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat.<ref>PMID:9753710</ref> Defects in PPARG are the cause of familial partial lipodystrophy type 3 (FPLD3) [MIM:[https://omim.org/entry/604367 604367]. Familial partial lipodystrophies (FPLD) are a heterogeneous group of genetic disorders characterized by marked loss of subcutaneous (sc) fat from the extremities. Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus and dyslipidemia.<ref>PMID:12453919</ref> <ref>PMID:11788685</ref> Genetic variations in PPARG can be associated with susceptibility to glioma type 1 (GLM1) [MIM:[https://omim.org/entry/137800 137800]. Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas. Note=Polymorphic PPARG alleles have been found to be significantly over-represented among a cohort of American patients with sporadic glioblastoma multiforme suggesting a possible contribution to disease susceptibility. | |||
== Function == | == Function == | ||
[https://www.uniprot.org/uniprot/PPARG_HUMAN PPARG_HUMAN] Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the receptor binds to a promoter element in the gene for acyl-CoA oxidase and activates its transcription. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses.<ref>PMID:9065481</ref> <ref>PMID:16150867</ref> <ref>PMID:20829347</ref> | |||
==See Also== | ==See Also== | ||
Line 20: | Line 19: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Fukakusa | [[Category: Fukakusa S]] | ||
[[Category: Fukui | [[Category: Fukui K]] | ||
[[Category: Harada | [[Category: Harada S]] | ||
[[Category: Hiromori | [[Category: Hiromori Y]] | ||
[[Category: Kawahara | [[Category: Kawahara K]] | ||
[[Category: Kobayashi | [[Category: Kobayashi Y]] | ||
[[Category: Nagase | [[Category: Nagase H]] | ||
[[Category: Nakamura | [[Category: Nakamura S]] | ||
[[Category: Nakanishi | [[Category: Nakanishi T]] | ||
[[Category: Nishikawa | [[Category: Nishikawa J]] | ||
[[Category: Noda | [[Category: Noda M]] | ||
[[Category: Ohkubo | [[Category: Ohkubo T]] | ||
[[Category: Uchiyama | [[Category: Uchiyama S]] | ||
[[Category: Yoshida | [[Category: Yoshida T]] | ||